THROMBOCYTOSIS AND SYMPTOMS IN MYELOPROLIFERATIVE DISORDERS - A RETROSPECTIVE STUDY

被引：0
|
作者：
GROSSI, A
ROSSETI, S
VANNUCCHI, AM
RAFANELLI, D
FERRINI, PR
机构：
来源：
CELLULAR BLOOD COMPONENTS IN HAEMOSTASIS AND THROMBOSIS: IMPLICATIONS FROM MYELOPROLIFERATIVE DISORDERS | 1988年 / 1卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205 / 207
页数：3
相关论文
共 50 条
  • [1] UNCONTROLLED THROMBOCYTOSIS IN CHRONIC MYELOPROLIFERATIVE DISORDERS
    KESSLER, CM
    KLEIN, HG
    HAVLIK, RJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1982, 50 (01) : 157 - 167
  • [2] Myeloproliferative disorders: A retrospective cohort study
    Ali, Rihan Mhmed
    Masoud, Verra
    ANNALS OF MEDICINE AND SURGERY, 2021, 68
  • [3] PLATELET PHOSPHOLIPIDS IN THROMBOCYTOSIS DUE TO MYELOPROLIFERATIVE DISORDERS
    BREUER, JH
    HARSANYI, V
    SOLTI, V
    HOLLAN, SR
    HAEMOSTASIS, 1981, 10 (03) : 134 - 140
  • [4] Toxicity of treatment with anagrelide for thrombocytosis in myeloproliferative disorders.
    Rosenbaum, H
    Bennet, M
    Braester, A
    Benyamini, N
    Chubar, I
    Rowe, JM
    BLOOD, 2002, 100 (11) : 798A - 798A
  • [5] Thrombocytosis and acquired bleeding disorders in patients with myeloproliferative neoplasms
    Simini, Giulia
    Vinayagam, Saravanan
    Karawitage, Nilanthi
    Mobayen, Golzar
    Krishnamoorthi, Anupama
    Innes, Andrew James
    Laffan, Michael
    Arachchillage, Deepa Jayakody
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 53 - 54
  • [6] Anagrelide for thrombocytosis in myeloproliferative disorders -: A prospective study to assess efficacy and adverse event profile
    Steurer, M
    Gastl, G
    Jedrzejczak, WW
    Pytlik, R
    Lin, WN
    Schlögl, E
    Gisslinger, H
    CANCER, 2004, 101 (10) : 2239 - 2246
  • [7] INTERFERON-ALFA CORRECTS THROMBOCYTOSIS IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS
    LUDWIG, H
    LINKESCH, W
    GISSLINGER, H
    FRITZ, E
    SINZINGER, H
    RADASZKIEWICZ, T
    CHOTT, A
    FLENER, R
    MICKSCHE, M
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 25 (03) : 266 - 273
  • [8] COMBINED PLATELETPHERESIS AND CYTOTOXIC CHEMOTHERAPY FOR SYMPTOMATIC THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS
    BARON, BW
    MICK, R
    BARON, JM
    CANCER, 1993, 72 (04) : 1209 - 1218
  • [9] TREATMENT OF THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS WITH INTERFERON ALPHA-2A
    TICHELLI, A
    GRATWOHL, A
    BERGER, C
    LORI, A
    WURSCH, A
    DIETERLE, A
    THOMSSEN, C
    NISSEN, C
    HOLDENER, E
    SPECK, B
    BLUT, 1989, 58 (01): : 15 - 19
  • [10] ALPHA-INTERFERON IN CHRONIC MYELOPROLIFERATIVE DISORDERS (CMPD) WITH THROMBOCYTOSIS
    MIDDELHOFF, G
    BOLL, I
    BLUT, 1988, 57 (04): : 232 - 232
12345